Back to Search
Start Over
Using the anterior capsule of the hip joint to protect the tensor fascia lata muscle during direct anterior total hip arthroplasty: a randomized prospective trial
- Source :
- BMC Musculoskeletal Disorders, BMC Musculoskeletal Disorders, Vol 21, Iss 1, Pp 1-10 (2020)
- Publication Year :
- 2019
- Publisher :
- Research Square Platform LLC, 2019.
-
Abstract
- Background The direct anterior approach for total hip arthroplasty (THA) has specific advantages, but injury to the tensor fasciae lata muscle (TFLM) remains a concern. This injury in part negates some of the advantages of the intermuscular approach, because injury of the muscle fibers of the TFLM can lead to less satisfactory clinical results. Thus, in this study, we propose an intraoperative method to protect the TFLM and demonstrate its feasibility. Methods Fifty-six patients undergoing THA by the direct anterior approach were divided randomly into two groups. In group A, the TFLM was protected by an autogenous tissue “pad” created from the anterior capsule of the joint which protect the TFLM from direct contact with the retractors. In group B, the operation was carried out with no protection of the TFLM except the attempt by the surgeons to consciously avoid injury of the TFLM. We evaluated magnitude of changes in the muscle cross-sectional area (MSCA) and fatty atrophy (FA) by magnetic resonance imaging. The differences in blood hemoglobin and serum levels of myoglobin, lactate dehydrogenase (LDH), and creatine phosphokinase (CPK) were compared at different time, postoperatively. The Harris hip score, postoperative drainage volume and visual analogue scores (VAS) were compared between the two groups. Results LDH, CPK and myoglobin in group B were significantly higher than group A at 8, 24, and 48 h after the surgery. (p P Conclusions Using the anterior capsule of the hip joint as an autogenous, protective capsular tissue pad to limit the trauma to the TFLM during a direct anterior approach to THA is an effective method to protect the TFLM and improve the clinical effect. Trial registration ChiCTR: ChiCTR1900025173. Retrospectively registered August 15, 2019.
- Subjects :
- Male
medicine.medical_specialty
lcsh:Diseases of the musculoskeletal system
Sports medicine
Arthroplasty, Replacement, Hip
Trauma
Group B
03 medical and health sciences
0302 clinical medicine
Rheumatology
Fascia lata
Capsular
Internal medicine
Fascia Lata
medicine
Humans
Orthopedics and Sports Medicine
Protect
030212 general & internal medicine
Tensor fasciae lata muscle
Prospective Studies
Aged
030222 orthopedics
medicine.diagnostic_test
biology
business.industry
Magnetic resonance imaging
Muscle cross-sectional area
Middle Aged
Surgery
Femoral Neck Fractures
medicine.anatomical_structure
Direct anterior approach
Harris Hip Score
Orthopedic surgery
biology.protein
Fatty atrophy
Creatine kinase
Total hip arthroplasty
Female
lcsh:RC925-935
business
Organ Sparing Treatments
Research Article
Subjects
Details
- ISSN :
- 19000251
- Database :
- OpenAIRE
- Journal :
- BMC Musculoskeletal Disorders, BMC Musculoskeletal Disorders, Vol 21, Iss 1, Pp 1-10 (2020)
- Accession number :
- edsair.doi.dedup.....230259bb17ed12d70b3cb70641618e11
- Full Text :
- https://doi.org/10.21203/rs.2.14815/v2